Anlotinib exerts anti‐cancer efficiency on lung cancer stem cells in vitro and in vivo through reducing NF‐κB activity

Anlotinib is a multi‐target tyrosine kinase inhibitor. Previous studies confirmed that anlotinib exerts anti‐cancer efficiency. However, the functional roles of anlotinib on cancer stem cells (CSCs) are yet to be elucidated. In this study, lung CSCs were isolated and identified in vitro, and mouse x...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Zhuohong, Tian, Juncai, Du, Lei, Gao, Ying, Wang, Yao, You, Fengming, Wang, Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8184695/
https://www.ncbi.nlm.nih.gov/pubmed/33955683
http://dx.doi.org/10.1111/jcmm.16564

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8184695/
https://www.ncbi.nlm.nih.gov/pubmed/33955683
http://dx.doi.org/10.1111/jcmm.16564

Ejemplares similares